Principal Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-106,183
| Closed | -$94.1K | – | 2523 |
|
|
2022
Q4 | $94.1K | Buy |
106,183
+22,657
| +27% | +$20.1K | ﹤0.01% | 2298 |
|
|
2022
Q3 | $131K | Buy |
83,526
+17,128
| +26% | +$26.9K | ﹤0.01% | 2281 |
|
|
2022
Q2 | $133K | Sell |
66,398
-19,266
| -22% | -$38.6K | ﹤0.01% | 2358 |
|
|
2022
Q1 | $200K | Buy |
85,664
+1,614
| +2% | +$3.77K | ﹤0.01% | 2340 |
|
|
2021
Q4 | $391K | Sell |
84,050
-26,662
| -24% | -$124K | ﹤0.01% | 2185 |
|
|
2021
Q3 | $845K | Buy |
110,712
+3,575
| +3% | +$27.3K | ﹤0.01% | 2051 |
|
|
2021
Q2 | $1.04M | Sell |
107,137
-3,212
| -3% | -$31.1K | ﹤0.01% | 2027 |
|
|
2021
Q1 | $913K | Sell |
110,349
-5,966
| -5% | -$49.4K | ﹤0.01% | 2014 |
|
|
2020
Q4 | $793K | Buy |
116,315
+46,454
| +66% | +$317K | ﹤0.01% | 1997 |
|
|
2020
Q3 | $778K | Buy |
69,861
+3,962
| +6% | +$44.1K | ﹤0.01% | 1918 |
|
|
2020
Q2 | $414K | Buy |
65,899
+29,195
| +80% | +$183K | ﹤0.01% | 2008 |
|
|
2020
Q1 | $67K | Buy |
36,704
+736
| +2% | +$1.34K | ﹤0.01% | 2143 |
|
|
2019
Q4 | $122K | Buy |
35,968
+4,028
| +13% | +$13.7K | ﹤0.01% | 2179 |
|
|
2019
Q3 | $68K | Buy |
31,940
+3,788
| +13% | +$8.07K | ﹤0.01% | 2201 |
|
|
2019
Q2 | $75K | Sell |
28,152
-47,869
| -63% | -$128K | ﹤0.01% | 2195 |
|
|
2019
Q1 | $361K | Sell |
76,021
-445
| -0.6% | -$2.11K | ﹤0.01% | 1998 |
|
|
2018
Q4 | $183K | Sell |
76,466
-16,112
| -17% | -$38.6K | ﹤0.01% | 2149 |
|
|
2018
Q3 | $408K | Buy |
92,578
+4,628
| +5% | +$20.4K | ﹤0.01% | 2006 |
|
|
2018
Q2 | $633K | Buy |
+87,950
| New | +$633K | ﹤0.01% | 1921 |
|